Efficacy and safety of NT 201, botulinum neurotoxin type A free from complexing proteins) in pre-treated cervical dystonia patients

被引：0
|
作者：
Grafe, S.
Comella, C.
Jankovic, J.
Truong, D.
Hanschmann, A.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [21] Safety, efficacy, and duration of effect of a new Botulinum Neurotoxin Type A preparation free of complexing proteins
    Wohlfarth, K
    Mueller, C
    MOVEMENT DISORDERS, 2005, 20 : S11 - S11
  • [22] SUSTAINED EFFICACY OF INCOBOTULINUMTOXIN-A (XEOMIN®; BOTULINUM NEUROTOXIN TYPE-A, FREE FROM COMPLEXING PROTEINS) IN LONG-TERM TREATMENT OF CERVICAL DYSTONIA
    Dressler, D.
    Kupsch, A.
    Paus, S.
    Seitzinger, A.
    Gebhardt, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 482 - 482
  • [23] Use of an interactive voice response system by patients with blepharospasm receiving repeated injections of NT 201 (botulinum neurotoxin type A free from complexing proteins)
    Marx, M.
    Grafe, S.
    Jankovic, J.
    Comella, C.
    MOVEMENT DISORDERS, 2010, 25 (07) : S243 - S243
  • [24] Repeated injections of NT 201 (botulinum neurotoxin free from complexing proteins) in upper limb post-stroke spasticity patients
    Kanovsky, P.
    Sassin, I.
    Comes, G.
    Grafe, S.
    Platz, T.
    MOVEMENT DISORDERS, 2009, 24 : S452 - S453
  • [25] A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
    Benecke, R
    Jost, WH
    Kanovsky, P
    Ruzicka, E
    Comes, G
    Grafe, S
    NEUROLOGY, 2005, 64 (11) : 1949 - 1951
  • [26] Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke
    Santamato, Andrea
    Panza, Francesco
    Ranieri, Maurizio
    Frisardi, Vincenza
    Micello, Maria Francesca
    Filoni, Serena
    Fortunato, Francesca
    Intiso, Domenico
    Basciani, Mario
    Logroscino, Giancarlo
    Fiore, Pietro
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (03) : 469 - 476
  • [27] Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke
    Andrea Santamato
    Francesco Panza
    Maurizio Ranieri
    Vincenza Frisardi
    Maria Francesca Micello
    Serena Filoni
    Francesca Fortunato
    Domenico Intiso
    Mario Basciani
    Giancarlo Logroscino
    Pietro Fiore
    Journal of Neural Transmission, 2013, 120 : 469 - 476
  • [28] An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia
    Zhou, Xuan
    Li, Zhen-Fei
    Guo, Xuan-Zhu
    Wei, Qiao
    Niu, Ya-Nan
    Li, Meng
    Xia, Jia-Ning
    Chen, Li-Ping
    TECHNOLOGY AND HEALTH CARE, 2024, 32 (04) : 2421 - 2430
  • [29] Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins
    Oh, Hyun-Mi
    Park, Joo Hyun
    Song, Dae Heon
    Chung, Myung Eun
    TOXINS, 2016, 8 (01):
  • [30] Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX®) in healthy volunteers
    Jost, WH
    Kohl, A
    Brinkmann, S
    Comes, G
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (07) : 905 - 913
12345